Logo image of EB

EVENTBRITE INC-CLASS A (EB) Stock Fundamental Analysis

NYSE:EB - New York Stock Exchange, Inc. - US29975E1091 - Common Stock - Currency: USD

2.47  -0.04 (-1.59%)

Premarket: 2.4 -0.07 (-2.83%)

Fundamental Rating

3

Taking everything into account, EB scores 3 out of 10 in our fundamental rating. EB was compared to 72 industry peers in the Entertainment industry. EB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EB had negative earnings in the past year.
EB had a positive operating cash flow in the past year.
EB had negative earnings in each of the past 5 years.
Of the past 5 years EB 4 years had a positive operating cash flow.
EB Yearly Net Income VS EBIT VS OCF VS FCFEB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.18%, EB is in line with its industry, outperforming 55.56% of the companies in the same industry.
EB has a Return On Equity (-10.21%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.18%
ROE -10.21%
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
EB Yearly ROA, ROE, ROICEB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

EB's Gross Margin of 68.73% is amongst the best of the industry. EB outperforms 80.56% of its industry peers.
In the last couple of years the Gross Margin of EB has grown nicely.
EB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
EB Yearly Profit, Operating, Gross MarginsEB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

EB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EB has been reduced compared to 1 year ago.
The number of shares outstanding for EB has been increased compared to 5 years ago.
The debt/assets ratio for EB has been reduced compared to a year ago.
EB Yearly Shares OutstandingEB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EB Yearly Total Debt VS Total AssetsEB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that EB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.68, EB is doing worse than 73.61% of the companies in the same industry.
The Debt to FCF ratio of EB is 9.61, which is on the high side as it means it would take EB, 9.61 years of fcf income to pay off all of its debts.
EB has a Debt to FCF ratio of 9.61. This is in the better half of the industry: EB outperforms 61.11% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that EB has dependencies on debt financing.
EB has a Debt to Equity ratio of 1.22. This is in the lower half of the industry: EB underperforms 68.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.61
Altman-Z -0.68
ROIC/WACCN/A
WACC6.49%
EB Yearly LT Debt VS Equity VS FCFEB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.45 indicates that EB should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.45, EB is doing good in the industry, outperforming 63.89% of the companies in the same industry.
EB has a Quick Ratio of 1.45. This is a normal value and indicates that EB is financially healthy and should not expect problems in meeting its short term obligations.
EB has a Quick ratio of 1.45. This is in the better half of the industry: EB outperforms 68.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
EB Yearly Current Assets VS Current LiabilitesEB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

EB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
EB shows a decrease in Revenue. In the last year, the revenue decreased by -6.52%.
The Revenue has been decreasing by -0.11% on average over the past years.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)-6.52%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-14.4%

3.2 Future

Based on estimates for the next years, EB will show a very strong growth in Earnings Per Share. The EPS will grow by 22.76% on average per year.
EB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.11% yearly.
EPS Next Y-48.44%
EPS Next 2Y2.26%
EPS Next 3Y-1.97%
EPS Next 5Y22.76%
Revenue Next Year-7.59%
Revenue Next 2Y1.57%
Revenue Next 3Y4.93%
Revenue Next 5Y4.11%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EB Yearly Revenue VS EstimatesEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
EB Yearly EPS VS EstimatesEB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EB Price Earnings VS Forward Price EarningsEB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EB is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.44
EV/EBITDA N/A
EB Per share dataEB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.26%
EPS Next 3Y-1.97%

More info and screens

0

5. Dividend

5.1 Amount

EB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVENTBRITE INC-CLASS A

NYSE:EB (7/24/2025, 8:04:00 PM)

Premarket: 2.4 -0.07 (-2.83%)

2.47

-0.04 (-1.59%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07
Inst Owners81.82%
Inst Owner Change0.16%
Ins Owners5.82%
Ins Owner Change22.67%
Market Cap236.85M
Analysts45
Price Target3.26 (31.98%)
Short Float %5.69%
Short Ratio6.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.02%
Min EPS beat(2)-64.87%
Max EPS beat(2)24.82%
EPS beat(4)3
Avg EPS beat(4)37.02%
Min EPS beat(4)-64.87%
Max EPS beat(4)118.39%
EPS beat(8)6
Avg EPS beat(8)35.4%
EPS beat(12)8
Avg EPS beat(12)28.4%
EPS beat(16)11
Avg EPS beat(16)22.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.29%
Min Revenue beat(2)-2.55%
Max Revenue beat(2)-2.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)-0.39%
Revenue beat(8)0
Avg Revenue beat(8)-2.62%
Revenue beat(12)1
Avg Revenue beat(12)-2.15%
Revenue beat(16)4
Avg Revenue beat(16)-0.15%
PT rev (1m)0%
PT rev (3m)-30.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.14%
EPS NY rev (1m)0%
EPS NY rev (3m)18.87%
Revenue NQ rev (1m)-1.6%
Revenue NQ rev (3m)-3.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF 9.44
P/OCF 7.51
P/B 1.37
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.26
FCFY10.59%
OCF(TTM)0.33
OCFY13.31%
SpS3.26
BVpS1.81
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.18%
ROE -10.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.73%
FCFM 8.02%
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.61
Debt/EBITDA N/A
Cap/Depr 41.41%
Cap/Sales 2.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z -0.68
F-Score5
WACC6.49%
ROIC/WACCN/A
Cap/Depr(3y)45.61%
Cap/Depr(5y)35.63%
Cap/Sales(3y)2.15%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-48.44%
EPS Next 2Y2.26%
EPS Next 3Y-1.97%
EPS Next 5Y22.76%
Revenue 1Y (TTM)-6.52%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-14.4%
Revenue Next Year-7.59%
Revenue Next 2Y1.57%
Revenue Next 3Y4.93%
Revenue Next 5Y4.11%
EBIT growth 1Y2.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.24%
EBIT Next 3Y46.86%
EBIT Next 5Y28.19%
FCF growth 1Y3036.25%
FCF growth 3Y-29.09%
FCF growth 5Y12.63%
OCF growth 1Y400.35%
OCF growth 3Y-23.38%
OCF growth 5Y4.42%